These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2108909)

  • 1. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.
    John M; Flam M; Sikic B; Rotman M; Cooper J; Malec M; Hannigan J; Phillips T
    Gynecol Oncol; 1990 Apr; 37(1):1-5. PubMed ID: 2108909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma.
    John M; Cooke JK; Flam M; Padmanabhan A; Mowry PA
    Gynecol Oncol; 1987 Sep; 28(1):101-10. PubMed ID: 3115871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
    Fishman A; Chiu JK; Girtanner RE; Dennis W; Carpenter LS; Lu HH; Woo SY; Kerley JM; Kaplan AL
    Am J Clin Oncol; 1997 Aug; 20(4):342-7. PubMed ID: 9256886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
    Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
    Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer. A phase II prospective study.
    Hsu WL; Shueng PW; Jen YM; Wu CJ; Liu HS; Su CC; Hwang JM
    Am J Clin Oncol; 1996 Jun; 19(3):263-7. PubMed ID: 8638538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
    Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies.
    Grigsby PW; Graham MV; Perez CA; Galakatos AE; Camel HM; Kao MS
    Am J Clin Oncol; 1996 Feb; 19(1):1-6. PubMed ID: 8554027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: a pilot study.
    Malviya VK; Deppe G; Kim Y; Gove N
    Am J Clin Oncol; 1989 Oct; 12(5):434-7. PubMed ID: 2508463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15.
    John M; Flam M; Caplan R; Rotman M; Quivey J; Steinfeld A; Russell A
    Gynecol Oncol; 1996 May; 61(2):221-6. PubMed ID: 8626137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report.
    Kuske RR; Perez CA; Grigsby PW; Lovett RD; Jacobs AJ; Galakatos AE; Camel HM; Kao MS
    Am J Clin Oncol; 1989 Dec; 12(6):467-73. PubMed ID: 2686392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix.
    Koumantakis E; Haralambakis Z; Koukourakis M; Mazonakis M; Haldeopoulos D; Papageorgiou N; Livas V; Froudarakis G; Varveris H
    Br J Radiol; 1998 May; 71(845):552-7. PubMed ID: 9691902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.